Pay in 4 interest-free payments of $6.39 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Evasive responses indicate potential problems
The rationale is that glucagon also increases energy expenditure and promotes hepatic fat mobilization, so a molecule that combines glucagons metabolic-rate effect with GLP-1/GIPs appetite-and-glucose control can, in principle, drive weight loss from both sides of the energy-balance equation at once
Some suggest AOD 9604 may preferentially target stubborn fat cells (areas with higher fat storage) and may also exert beneficial effects on cartilage/ bone/ connective tissue (though those are more speculative)
But for many, injections arent the most convenient or preferred choice
Gastrointestinal side effects Nausea, vomiting, and diarrhea may contribute to dehydration and electrolyte imbalances
B., Chan, G
US$ 20.17
US$ 28.75
US$ 22.42
